International Conference on AI-Enabled Drug Discovery and Molecular Therapeutics

Important dates

1. 30 Nov

   Abstract / full paper deadline

   In 15 days

2. 1 Jan

   Conference

   Macapa, Brazil

All deadlines are as published by the organizer. Check the official website for the time zone.

About this conference

Focusing on the impact of artificial intelligence in pharmaceutical innovation, this conference offers a platform for sharing research and case studies on AI-enabled drug discovery and molecular therapeutics. Researchers, practitioners, and stakeholders are invited to submit contributions that reflect current trends and challenges in this rapidly evolving field. The program includes formats such as oral presentations and poster sessions to accommodate a variety of research outputs. Participants will benefit from interactive discussions that aim to enhance the understanding of AI’s role in developing effective therapies. Opportunities for collaboration and networking will abound, providing a chance to connect with like-minded professionals. Details about submission processes, registration, and featured speakers will be published on the official conference platform. Become a part of this vital dialogue on integrating AI into the drug development pipeline and its implications for the future of medicine.

Call for papers

Abstracts are due by 30 November 2026. Submission details are on the official website.